Back to resultsHigh Field Magnetic Resonance Spectroscopy Imaging for Follow Up of Prostate Cancer Post Brachytherapy Implantation
Primary Purpose
Prostatic Neoplasm
Status
Completed
Phase
Not Applicable
Locations
Canada
Study Type
Interventional
Intervention
Magnetic Resonance Spectroscopy Imaging
Sponsored by
About this trial
This is an interventional diagnostic trial for Prostatic Neoplasm focused on measuring brachytherapy, magnetic resonance spectroscopy
Eligibility Criteria
Inclusion Criteria: Suitable candidate for prostate brachytherapy to treat prostate cancer Patient signs a study consent form Exclusion Criteria: Have received other radiotherapy for prostate cancer or hormone treatments Has contraindication to MRSI scanning Does not sign study consent form
Sites / Locations
- Cross Cancer Institute
Outcomes
Primary Outcome Measures
pilot study meant to establish scanning parameters on 3T MRSI
Secondary Outcome Measures
safety/toxicity
Full Information
NCT ID
NCT00126854
First Posted
August 3, 2005
Last Updated
February 24, 2016
Sponsor
AHS Cancer Control Alberta
Collaborators
Cross Cancer Institute
1. Study Identification
Unique Protocol Identification Number
NCT00126854
Brief Title
High Field Magnetic Resonance Spectroscopy Imaging for Follow Up of Prostate Cancer Post Brachytherapy Implantation
Official Title
High Field (3 Tesla) Magnetic Resonance Spectroscopy Imaging for Follow Up of Prostate Cancer Post Permanent Iodine 125 Brachytherapy Implantation
Study Type
Interventional
2. Study Status
Record Verification Date
March 2012
Overall Recruitment Status
Completed
Study Start Date
October 2005 (undefined)
Primary Completion Date
April 2011 (Actual)
Study Completion Date
April 2011 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
AHS Cancer Control Alberta
Collaborators
Cross Cancer Institute
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
The purpose of this study is to establish the correct scanning parameters for obtaining good quality 3 Tesla (3T) magnetic resonance spectroscopy images (MRSI) of the prostate gland before and after brachytherapy implantation for prostate cancer. Three Tesla MRSI may be a valuable additional diagnostic and follow-up investigation for prostate cancer patients.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Prostatic Neoplasm
Keywords
brachytherapy, magnetic resonance spectroscopy
7. Study Design
Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
10 (Actual)
8. Arms, Groups, and Interventions
Intervention Type
Procedure
Intervention Name(s)
Magnetic Resonance Spectroscopy Imaging
Primary Outcome Measure Information:
Title
pilot study meant to establish scanning parameters on 3T MRSI
Secondary Outcome Measure Information:
Title
safety/toxicity
10. Eligibility
Sex
Male
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Suitable candidate for prostate brachytherapy to treat prostate cancer
Patient signs a study consent form
Exclusion Criteria:
Have received other radiotherapy for prostate cancer or hormone treatments
Has contraindication to MRSI scanning
Does not sign study consent form
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Don Yee, MD
Organizational Affiliation
AHS Cancer Control Alberta
Official's Role
Principal Investigator
Facility Information:
Facility Name
Cross Cancer Institute
City
Edmonton
State/Province
Alberta
ZIP/Postal Code
T6G 1Z2
Country
Canada
12. IPD Sharing Statement
Learn more about this trial
High Field Magnetic Resonance Spectroscopy Imaging for Follow Up of Prostate Cancer Post Brachytherapy Implantation
We'll reach out to this number within 24 hrs